Indivior plunges after losing court battle over its No1 addiction drug

Shares in Indivior nosedived yesterday after the addiction treatment specialist lost a key court battle over Suboxone, cutting delays to release of cheaper generic versions of the opioid addiction treatment by rivals Dr Reddy’s Laboratories and Teva Pharmaceuticals.